HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dithiocyanatoiron reagent

reagent used for colorimetric determination of phospholipids; contains ferric nitrate & ammonium thiocyanate

Also Known As:

DTCR

Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Iron Compounds: 87
  - Ferric Compounds: 6
    - dithiocyanatoiron reagent: 4
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiocyanates: 28
    - dithiocyanatoiron reagent: 4
- Cyanates: 131
  - Thiocyanates: 28
    - dithiocyanatoiron reagent: 4

Experts

1.	Patel, Bhoomika: 2 articles (10/2021 - 12/2020)
2.	Rawal, Shruti: 2 articles (10/2021 - 12/2020)
3.	Bora, Vivek: 1 article (10/2021)
4.	Patel, Mayur: 1 article (10/2021)
5.	Guo, Changjiang: 1 article (12/2020)
6.	Li, Mingfeng: 1 article (12/2020)
7.	Lu, Chengui: 1 article (12/2020)
8.	Patel, Mayur M: 1 article (12/2020)
9.	Yin, Meichen: 1 article (12/2020)
10.	Zhang, Huiyong: 1 article (12/2020)

Related Diseases

1.	Neoplasms (Cancer) 10/01/2022 - "The combination of DAC with NY-ESO-1-specific dTCR-T cells showed a superior anti-tumor efficacy in vivo and prolonged the survival of an AML xenograft mouse model, with three out of five mice showing complete elimination of AML cells over 90 days. " 12/01/2020 - "Collectively, we demonstrated that expression of DTCR markedly augmented the cytotoxic potential of NK92 cells against solid tumor cells, and this potentially promising treatment modality will facilitate clinical translation of potent NK-tailored chimeric receptor strategy for a generalized cellular therapy that may be conducive to treat a wide range of solid tumors." 10/01/2021 - "Immunostaining of the tumor sections with tumor differentiation biomarkers suggested considerably higher apoptotic, anti-proliferative, anti-angiogenic, and anti-metastatic potential of FA-DTCR-NLCs compared with Taxotere®. " 12/01/2020 - "To this end, we developed a structure-based rational design approach and constructed a novel Dual Targeting Chimeric Receptor (DTCR) PD1-DAP10/NKG2D comprising the truncated ectodomain of PD1 fused to a key co-stimulatory receptor DAP10, and subsequently harnessed the activating receptor NKG2D, which evaluated the capacity of solid tumor cell killing. "
2.	Leukemia 10/01/2022 - "Moreover, the incubation of T cells with DAC during TCR transduction (designated as dTCR-T cells) could further enhance the anti-leukemia efficacy of TCR-T cells and increase the generation of memory-like phenotype. "
3.	Lung Neoplasms (Lung Cancer) 10/01/2021 - "The current research was instigated to facilitate targeted and ratiometric co-delivery of docetaxel (DT) and curcumin (CR) through the development of folate (FA)-appended nanostructured lipid carriers (NLCs), i.e., FA-DTCR-NLCs to lung cancer cells. "
4.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/01/2020 - "To develop docetaxel (DT) and curcumin (CUR) co-loaded nanostructured lipid carriers (DTCR-NLCs) for ratiometric co-targeting to non-small cell lung carcinoma (NSCLC) cells. "

Related Drugs and Biologics

1.	Lipids
2.	Curcumin
3.	Docetaxel (Taxotere)
4.	NK Cell Lectin-Like Receptor Subfamily K
5.	Biomarkers (Surrogate Marker)
6.	Folic Acid (Vitamin M)

Related Therapies and Procedures

1.	Therapeutics